|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2018
Ku, Cheol Ryong; Brue, Thierry; Schilbach, Katharina; Ignatenko, Stanislav; Magony, Sandor; Chung, Yoon-Sok; Kim, Byung-Joon; Hur, Kyu Yeon; Kang, Ho-Cheol; Kim, Jung Hee; Ki, Min Seon; Kowalska, Aldona; Bolanowski, Marek; Ruchala, Marek; Damjanovic, Svetozar; Payer, Juraj; Choi, Yun Jung; Heo, Su Jin; Kim, Tae Kyoung; Heo, MinKyu; Lee, Joan und Lee, Eun Jig
(2018):
Long-acting FC-fusion rhGH (GX-H9) shows potential for up to twice-monthly administration in GH-deficient adults.
In: European Journal of Endocrinology, Bd. 179, Nr. 3: S. 169-179
2017
Strasburger, Christian J.; Vanuga, Peter; Payer, Juraj; Pfeifer, Marija; Popovic, Vera; Bajnok, László; Góth, Miklós; Olšovská, Vera; Trejbalová, Ludmila; Vadasz, Janos; Fima, Eyal; Koren, Ronit; Amitzi, Leanne; Bidlingmaier, Martin; Hershkovitz, Oren; Hart, Gili und Biller, Beverly M. K.
(2017):
MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults.
In: European Journal of Endocrinology, Bd. 176, Nr. 3: S. 283-294